Our products do not constitute drugs as defined by the Federal Food, Drug, and Cosmetic Act and are not intended to diagnose, treat, cure, or prevent any disease or medical condition
Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options
Research-grade peptides purchased online carry serious and unpredictable risks because they are unregulated and labeled not for human use. At Formation in Tampa, Dr
Many recipients report faster, more noticeable results compared to oral supplementation
it is supplied as a chemical reagent for laboratory use